Tag Archives: Clinical Trials
By Guest Blogger | Published: March 7, 2014
By Kevin Jones. Historically, pharmaceutical companies have leveraged remote patient monitoring (RPM) in a very limited way to improve data collection in clinical trials. A handful of Pharma companies have studied RPM as part of a treatment protocol and studied improvements in patient outcomes. This begs the question: Why hasn’t RPM caught on?
By Marylyn Donahue | Published: March 7, 2014
Just think what Frankenstein could do with this product. It looks like skin, feels like skin, but it’s not skin. It’s LabSkin, a facsimile, being manufactured by a clinical research group Venn Life Sciences. Demand for replacement technologies stemmed from the European Union ban on selling cosmetics tested on animals in March 2013, proving where […]
By Guest Blogger | Published: February 24, 2014
Risk-Based Monitoring: From the Road Less Traveled to Productivity Superhighway By: Mukhtar Ahmed, global vice president, life sciences strategy, Oracle Health Sciences The latest news on the growing cost of conducting clinical trials is becoming a major concern for company sponsors and trial co-operative groups. Clinical trials cost 60% more today than they did just […]
By Guest Blogger | Published: February 12, 2014
By Moe Alsumidaie. The clinical trial technological landscape continues to morph, as we are starting to see the emergence of novel technologies and techniques to enhance clinical trial strategies and productivity. Study site/enrollment optimization, patient engagement, and big data were hot topics at this year’s SCOPE Summit in Miami, FL, last week.
By Guest Blogger | Published: January 27, 2014
By Peter O’ Donnell. To believe the European Parliament, the battle to create new clinical trials rules for the European Union is over. On January 22, the parliament’s health committee adopted the draft report prepared last year by one of its leading members. “Clearer rules, better protection for patients,” trumpeted the parliament’s press machine after […]